Pediatric Sepsis by Multi-Drugs Resistance Organism: Length of Stay, Prognosis, and Hospitalization Cost Evaluation

Multi-Drugs Resistance (MDR) is a condition where bacteria are resistant to at least one type of antibiotic from three classes antibiotics. One the organisms included in MDR an Extended-Spectrum Beta Lactamase (ESBL) producing bacteria. Multi-drug resistance have been widely reported globally as cause severe infections. Still, information on comparison Length Stay (LOS), hospitalization costs, and outcome status patients infected with non-MDR still limited. This study aimed compare LOS, treatment BPJS pediatric sepsis Dr. Soetomo General Academic Hospital, Surabaya. was observational research using medical records hospitalized insurance Hospital January 2015-July 2018 (n=49). The variables this were microbiology culture results antibiotics sensitivity tests, INA-CBGs rates provided by BPJS, actual cost, status. Statistical analyses performed INA-CBGs, (ESBL non-ESBL) or include average LOS value non-MDR, ESBL, non-ESBL cases, which 30.55; 46.18; 32.41. Comparison cost 0.886 0.990, respectively, p>0.05, each percentage mortality 27.3%, 45.5%, 40.7%. There no significant difference Each also not much different. tended be treated longer, require higher worseprognosis.